Top 7 Companies in the Chromhidrosis Treatment Market in 2025

The chromhidrosis treatment market is expected to grow at a CAGR of 3.20% during the forecast period of 2025-2034. The market is driven by the rising advancements in medical treatments and heightened consumer awareness of rare disorders.

Chromhidrosis is a rare condition characterized by the secretion of colored sweat due to pigment accumulation in apocrine glands. Treatment approaches include the use of botulinum toxin injections, laser therapy, and topical medications, which aim to reduce sweat production and alleviate symptoms. Medical professionals assess individual cases to determine the most suitable intervention based on severity and patient history. These treatments are supported by ongoing clinical research and have shown promising results in symptom management. Effective patient care involves a combination of therapies and regular follow‐up to monitor progress.

The chromhidrosis treatment market is experiencing moderate growth driven by increasing demand for advanced medical procedures and rising awareness of rare dermatological conditions. Recent technological innovations and expanded research into effective treatment methods have contributed to market expansion. Pharmaceutical companies and medical device manufacturers are investing significantly in developing novel therapeutic solutions. Government initiatives and favorable regulatory frameworks further support market growth.

According to the medical journal Pediatrics, chromhidrosis can be effectively managed with topical capsaicin cream 0.025% applied one to two times per day. Botox injections are also a viable alternative. As chromhidrosis is a chronic condition, sustained treatment is necessary, boosting the market growth for advanced therapies.

Let’s explore the profile of top companies leading the chromhidrosis treatment market in 2025.

1.    Evolus Ltd.

Evolus Ltd. has carved a niche in the realm of aesthetic medicine, with a specific focus on neurotoxins used for cosmetic treatments. Its deep-rooted expertise in neurotoxin development hints at promising potential for addressing excessive sweating issues. It operates as a performance beauty company that specializes in a broad array of aesthetic products. Their hallmark product, Jeuveau, is a botulinum toxin type A formulation that has received regulatory approval for diminishing glabellar lines. Recognizing that botulinum toxin has been successfully employed in chromhidrosis treatment, the Evolus brand continues to broaden its footprint within both the aesthetic and medical dermatology sectors.

2.    AbbVie Inc.

Headquartered in Illinois, United States, and established in 2013, AbbVie Inc. stands out as a pioneer in innovative aesthetic solutions. Marking a significant milestone in September 2024, the company introduced Botox Cosmetic, specifically formulated to treat masseter muscle prominence, through its Allergan Aesthetics division. With a steadfast commitment to leveraging robust clinical evidence and an impressive safety profile, AbbVie is actively exploring new frontiers, including promising applications in the chromhidrosis treatment market, thereby reinforcing its position as a leader in aesthetic innovation.

3.    Ipsen Pharma

Ipsen, a global biopharmaceutical company, has been at the forefront of advanced treatment solutions since its establishment in 1929. Headquartered in Paris, France, the company has built a robust portfolio of cutting-edge therapies. In 2023, Ipsen garnered notable market attention with its investigational liquid botulinum toxin type A product, known as QM-1114. Although this product primarily targets aesthetic indications, its development underscores Ipsen’s enduring commitment to refining treatment modalities for complex conditions, including those within the chromhidrosis treatment market, thereby merging aesthetic and therapeutic innovation.

4.    Galderma

Since its inception in 1981, Galderma has emerged as a global leader in dermatology, dedicated to pioneering innovative treatment approaches. The company’s comprehensive portfolio spans advanced injectable aesthetics, specialized dermatological skincare, and therapeutic dermatology products, which are meticulously designed to address a variety of skin conditions, including chromhidrosis. Through sustained research and development efforts, Galderma continuously contributes to the chromhidrosis treatment market by offering refined and optimal solutions tailored to unique dermatological challenges around the globe.

5.    Hughs

Based in Maryland, United States, Hughs distinguishes itself by utilizing a patented biotransformation process designed to maximize the efficacy and sustainability of polyphenols. Through an innovative bio-platform, the company transforms naturally occurring polyphenols into compounds that are highly water-soluble and improve superior bioavailability. This technological prowess is exemplified by signature products such as RenoSorb™, RenoFlavone™, and RenoCidin™. In the chromhidrosis treatment market, these advanced formulations play a crucial role in enhancing the absorption of active ingredients and boosting therapeutic effectiveness, thereby providing promising solutions for managing excessive sweating and improving overall skin health and treatment outcomes.

6.    Medytox

Medytox is a leading biopharmaceutical company specializing in innovative neurotoxin therapies. It has developed a range of Botulinum Toxin Type A products, including Neuronox, Innotox, Coretox, and NEWLUX, which can be used for the chromhidrosis treatment. Each product features the active ingredient Clostridium botulinum toxin type A (Hall strain) in either lyophilized or liquid form. Medytox continues to expand its involvement in research and development to improve treatment outcomes globally.

7.    Supernus Pharmaceuticals

Supernus Pharmaceuticals, headquartered in Maryland, United States, and established in 2005, is known for its innovative therapeutic solutions. Its neurology portfolio features products analogous to Botox, widely recognized for cosmetic and therapeutic applications. Although primarily focused on central nervous system disorders, the company’s robust pipeline and research in botulinum toxin therapies show promise for treating conditions such as chromhidrosis. This approach may offer a minimally invasive alternative for managing abnormally colored sweat, paralleling Botox’s success in hyperhidrosis treatment.